John Sourbeer analyst

Currently out of the existing stock ratings of John Sourbeer, 50 are a BUY (40.32%), 70 are a HOLD (56.45%), 4 are a SELL (3.23%).

John Sourbeer

Work Performance Price Targets & Ratings Chart

Analyst John Sourbeer, has had 54.93% of price targets met with an average potential upside of 11.75%, reached in 199 days on average. Previously, John Sourbeer worked at UBS.

John Sourbeer has documented 243 price targets and ratings displayed on 21 stocks. The coverage was on Healthcare, Industrials, Basic Materials sectors.

Most recent stock forecast was given on WST, West Pharmaceutical Services at 16-Feb-2026.

Wall Street Analyst John Sourbeer

Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for PACB (PACIFIC BIOSCIENCES OF CALIFORNIA) on 11/11/2024. The price target of $2 was fulfilled within 2 days with a profit of $0.46 (18.7%), with a performance score of 93.5.

Average potential price target upside

OCDX Ortho Clinical Diagnostics Holdings plc STVN Stevanato Group SpA TMO Thermo Fisher Scientific CYRX Cryoport IQV IQVIA Holdings OMIC Singular Genomics Systems MEDP Medpace Holdings ZY Zymergen BRKR Bruker CTLT Catalent QGEN Qiagen NV AKYA Akoya Biosciences ICLR ICON PLC MRVI Maravai Lifesciences Holdings TXG 10X Genomics NSTG NanoString Technologies PACB Pacific Biosciences of California SYNH Syneos Health WST West Pharmaceutical Services ILMN Illumina QDEL Quidel

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 06-May-2022

$18.19

4 years 6 months 16 days ago
(06-May-2022)

0/3 (0%)

$0.83 (4.78%)

Hold Since 17-Feb-2022

$20

4 years 9 months 5 days ago
(17-Feb-2022)

0/5 (0%)

$3.83 (23.69%)

Hold Since 17-Feb-2022

$17

$28

4 years 9 months 5 days ago
(17-Feb-2022)

1/3 (33.33%)

$0.83 (5.13%)

1

Hold Since 28-Dec-2021

$21

4 years 9 months 5 days ago
(17-Feb-2022)

0/3 (0%)

$4.83 (29.87%)

Buy Since 22-Feb-2021

$24.68

$30

4 years 10 months 25 days ago
(28-Dec-2021)

0/3 (0%)

$4.38 (21.58%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?